|
vesicle mediated transport
|
GO:0016192 |
381 |
0.327
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
3 |
0.307
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
153 |
0.273
|
|
|
rrna processing
|
GO:0006364 |
3 |
0.142
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
201 |
0.137
|
|
|
sex differentiation
|
GO:0007548 |
81 |
0.125
|
|
|
dna templated transcription elongation
|
GO:0006354 |
18 |
0.124
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
206 |
0.122
|
|
|
reproductive system development
|
GO:0061458 |
74 |
0.114
|
|
|
endocytosis
|
GO:0006897 |
310 |
0.101
|
|
|
intracellular transport
|
GO:0046907 |
228 |
0.099
|
|
|
muscle cell differentiation
|
GO:0042692 |
103 |
0.078
|
|
|
phosphorylation
|
GO:0016310 |
294 |
0.075
|
|
|
rna processing
|
GO:0006396 |
147 |
0.074
|
|
|
protein polymerization
|
GO:0051258 |
42 |
0.070
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
69 |
0.068
|
|
|
multi multicellular organism process
|
GO:0044706 |
123 |
0.068
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
74 |
0.067
|
|
|
regulation of intracellular signal transduction
|
GO:1902531 |
236 |
0.067
|
|
|
positive regulation of rna metabolic process
|
GO:0051254 |
271 |
0.066
|
|
|
gonad development
|
GO:0008406 |
50 |
0.066
|
|
|
reproductive structure development
|
GO:0048608 |
74 |
0.063
|
|
|
developmental growth
|
GO:0048589 |
280 |
0.062
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
151 |
0.061
|
|
|
protein complex biogenesis
|
GO:0070271 |
201 |
0.061
|
|
|
positive regulation of phosphate metabolic process
|
GO:0045937 |
139 |
0.057
|
|
|
body morphogenesis
|
GO:0010171 |
2 |
0.055
|
|
|
oviposition
|
GO:0018991 |
19 |
0.052
|
|
|
multi organism behavior
|
GO:0051705 |
175 |
0.050
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
354 |
0.049
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
50 |
0.049
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
80 |
0.049
|
|
|
phagocytosis
|
GO:0006909 |
215 |
0.048
|
|
|
positive regulation of phosphorus metabolic process
|
GO:0010562 |
139 |
0.048
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
89 |
0.047
|
|
|
wnt signaling pathway
|
GO:0016055 |
98 |
0.047
|
|
|
regulation of cell cycle process
|
GO:0010564 |
181 |
0.046
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
223 |
0.045
|
|
|
larval development
|
GO:0002164 |
104 |
0.045
|
|
|
protein modification process
|
GO:0036211 |
438 |
0.045
|
|
|
rna interference
|
GO:0016246 |
27 |
0.045
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
88 |
0.043
|
|
|
regulation of meiosis
|
GO:0040020 |
3 |
0.042
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.042
|
|
|
intracellular signal transduction
|
GO:0035556 |
300 |
0.042
|
|
|
myofibril assembly
|
GO:0030239 |
36 |
0.041
|
|
|
macromolecular complex assembly
|
GO:0065003 |
256 |
0.041
|
|
|
regulation of transcription elongation from rna polymerase ii promoter
|
GO:0034243 |
15 |
0.040
|
|
|
protein complex assembly
|
GO:0006461 |
200 |
0.040
|
|
|
mitotic g2 m transition checkpoint
|
GO:0044818 |
70 |
0.039
|
|
|
rna splicing
|
GO:0008380 |
83 |
0.039
|
|
|
centrosome cycle
|
GO:0007098 |
137 |
0.038
|
|
|
regulation of dna templated transcription elongation
|
GO:0032784 |
17 |
0.038
|
|
|
meiotic cell cycle
|
GO:0051321 |
171 |
0.038
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
42 |
0.037
|
|
|
establishment of localization in cell
|
GO:0051649 |
402 |
0.037
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
22 |
0.037
|
|
|
cell cycle phase transition
|
GO:0044770 |
140 |
0.036
|
|
|
actin filament based process
|
GO:0030029 |
220 |
0.036
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
130 |
0.035
|
|
|
regulation of rna splicing
|
GO:0043484 |
69 |
0.035
|
|
|
regulation of phosphorus metabolic process
|
GO:0051174 |
210 |
0.035
|
|
|
cytoplasmic transport
|
GO:0016482 |
130 |
0.035
|
|
|
positive regulation of dna endoreduplication
|
GO:0032877 |
4 |
0.034
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
103 |
0.033
|
|
|
positive regulation of signaling
|
GO:0023056 |
243 |
0.033
|
|
|
transcription elongation from rna polymerase ii promoter
|
GO:0006368 |
18 |
0.033
|
|
|
organic substance transport
|
GO:0071702 |
257 |
0.033
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
168 |
0.032
|
|
|
cellular protein complex assembly
|
GO:0043623 |
71 |
0.031
|
|
|
ribonucleoprotein complex biogenesis
|
GO:0022613 |
31 |
0.030
|
|
|
apoptotic process
|
GO:0006915 |
159 |
0.029
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
73 |
0.029
|
|
|
dna integrity checkpoint
|
GO:0031570 |
81 |
0.028
|
|
|
regulation of developmental growth
|
GO:0048638 |
174 |
0.028
|
|
|
regulation of phosphate metabolic process
|
GO:0019220 |
210 |
0.028
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
103 |
0.028
|
|
|
mitotic g2 dna damage checkpoint
|
GO:0007095 |
69 |
0.028
|
|
|
multi organism reproductive behavior
|
GO:0044705 |
121 |
0.028
|
|
|
mrna cis splicing via spliceosome
|
GO:0045292 |
1 |
0.027
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
45 |
0.027
|
|
|
reproductive behavior
|
GO:0019098 |
122 |
0.026
|
|
|
regulation of catalytic activity
|
GO:0050790 |
185 |
0.025
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
1 |
0.025
|
|
|
regulation of protein polymerization
|
GO:0032271 |
28 |
0.024
|
|
|
positive regulation of signal transduction
|
GO:0009967 |
223 |
0.024
|
|
|
regulation of protein stability
|
GO:0031647 |
43 |
0.024
|
|
|
positive regulation of gene expression
|
GO:0010628 |
290 |
0.024
|
|
|
ras protein signal transduction
|
GO:0007265 |
88 |
0.024
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
138 |
0.024
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
318 |
0.024
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
108 |
0.024
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
73 |
0.023
|
|
|
spindle organization
|
GO:0007051 |
253 |
0.023
|
|
|
glial cell migration
|
GO:0008347 |
31 |
0.023
|
|
|
gene silencing by rna
|
GO:0031047 |
57 |
0.023
|
|
|
stem cell differentiation
|
GO:0048863 |
117 |
0.023
|
|
|
eye development
|
GO:0001654 |
323 |
0.022
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
64 |
0.022
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
145 |
0.022
|
|
|
cell proliferation
|
GO:0008283 |
299 |
0.021
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
57 |
0.021
|
|
|
positive regulation of macromolecule metabolic process
|
GO:0010604 |
405 |
0.021
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
323 |
0.021
|
|
|
regulation of cell cycle
|
GO:0051726 |
291 |
0.021
|
|
|
imaginal disc derived appendage morphogenesis
|
GO:0035114 |
395 |
0.021
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
103 |
0.020
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
127 |
0.020
|
|
|
regulation of phosphorylation
|
GO:0042325 |
147 |
0.020
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
75 |
0.019
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
166 |
0.019
|
|
|
negative regulation of cytoskeleton organization
|
GO:0051494 |
30 |
0.019
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
73 |
0.019
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
165 |
0.018
|
|
|
regulation of molecular function
|
GO:0065009 |
217 |
0.018
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
90 |
0.018
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
107 |
0.018
|
|
|
positive regulation of transcription from rna polymerase ii promoter
|
GO:0045944 |
204 |
0.018
|
|
|
meiotic nuclear division
|
GO:0007126 |
151 |
0.017
|
|
|
regulation of neurogenesis
|
GO:0050767 |
158 |
0.017
|
|
|
regulation of cell differentiation
|
GO:0045595 |
302 |
0.017
|
|
|
cell division
|
GO:0051301 |
248 |
0.016
|
|
|
mapk cascade
|
GO:0000165 |
107 |
0.016
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
127 |
0.016
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.016
|
|
|
defense response
|
GO:0006952 |
300 |
0.016
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
68 |
0.016
|
|
|
protein phosphorylation
|
GO:0006468 |
169 |
0.015
|
|
|
positive regulation of biosynthetic process
|
GO:0009891 |
316 |
0.015
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
72 |
0.015
|
|
|
regulation of localization
|
GO:0032879 |
275 |
0.015
|
|
|
striated muscle cell development
|
GO:0055002 |
50 |
0.015
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
152 |
0.014
|
|
|
positive regulation of developmental growth
|
GO:0048639 |
62 |
0.014
|
|
|
immune system development
|
GO:0002520 |
57 |
0.014
|
|
|
centrosome organization
|
GO:0051297 |
163 |
0.014
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
87 |
0.013
|
|
|
positive regulation of cell communication
|
GO:0010647 |
250 |
0.013
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
63 |
0.013
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
170 |
0.013
|
|
|
nucleobase containing compound transport
|
GO:0015931 |
56 |
0.013
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
130 |
0.013
|
|
|
muscle cell development
|
GO:0055001 |
50 |
0.013
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
145 |
0.013
|
|
|
chromatin remodeling
|
GO:0006338 |
72 |
0.013
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
332 |
0.013
|
|
|
molting cycle
|
GO:0042303 |
56 |
0.013
|
|
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
60 |
0.013
|
|
|
chromatin organization
|
GO:0006325 |
207 |
0.012
|
|
|
nucleotide catabolic process
|
GO:0009166 |
109 |
0.012
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
43 |
0.012
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
109 |
0.012
|
|
|
positive regulation of mrna processing
|
GO:0050685 |
4 |
0.012
|
|
|
myosin filament assembly
|
GO:0031034 |
5 |
0.012
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
109 |
0.012
|
|
|
response to external biotic stimulus
|
GO:0043207 |
293 |
0.011
|
|
|
synapse organization
|
GO:0050808 |
196 |
0.011
|
|
|
transcription initiation from rna polymerase ii promoter
|
GO:0006367 |
25 |
0.011
|
|
|
positive regulation of protein polymerization
|
GO:0032273 |
14 |
0.011
|
|
|
stem cell maintenance
|
GO:0019827 |
67 |
0.011
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
9 |
0.011
|
|
|
positive regulation of macromolecule biosynthetic process
|
GO:0010557 |
283 |
0.011
|
|
|
myosin filament organization
|
GO:0031033 |
5 |
0.011
|
|
|
heterocycle catabolic process
|
GO:0046700 |
166 |
0.011
|
|
|
cell cycle checkpoint
|
GO:0000075 |
95 |
0.011
|
|
|
positive regulation of cellular biosynthetic process
|
GO:0031328 |
316 |
0.011
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
31 |
0.011
|
|
|
negative regulation of gene expression
|
GO:0010629 |
387 |
0.010
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
109 |
0.010
|
|
|
cell death
|
GO:0008219 |
279 |
0.010
|
|
|
nitric oxide metabolic process
|
GO:0046209 |
1 |
0.010
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
109 |
0.010
|
|